October 20 ,2026
Envisagenics announced that it has been awarded a Direct to Phase II SBIR grant from the National Cancer Institute (NCI). The award will provide more than $2 million over two years to support further development an...
Learn MoreCongratulations to CFB Innovator and Stony Brook University Professor Dr. M. Hassan Arbab on securing an award from the SUNY Technology Accelerator Fund! The SUNY Technology Accelerator Fund (TAF) helps support ...
Learn MoreOur colleagues at Envisagenics recently announced their strategic multi-year collaboration with Boehringer Ingelheim to advance the development of next-generation oncology therapies. This partnership brings togethe...
Learn MoreApplications are now open for the 12th BioREACH Award Program from the Center for Biotechnology, which provides $50,000 in translational research funding for Stony Brook faculty and postdoctoral researchers to generate the evidence needed to advance promising innovations to the …
Learn MoreStony Brook Medicine’s Science and Research Awareness Series, better known as SARAS, celebrated its 22nd year this summer.n The Center for Biotechnology is a long-term supporter of the event as it speaks to our passion for helping to train the …
Learn MoreAttention Stony Brook University Faculy and Staff: Applications for the second cycle of the President’s Fast Impact Fund (FIF) opened August 3, 2026. Open to all Stony Brook faculty and staff, this special initiative supports immediate-impact projects that can be …
Learn MoreThe College of Business at Stony Brook University invites applications for a non-tenure track part time lecturer position to teach Biotechnology Enterprises – Finance & Operations during the Fall 2026 semester. The successful candidate will demonstrate a passion for teaching, …
Learn MoreNew York State-based Startup companies have the opportunity to compete for a share of up to $420,000 in funding to accelerate the commercialization their innovative technology or product. As part of the Jeff Lawrence Innovation Fund, FuzeHub will hold its …
Learn MoreWe have exciting news to share for one of our Cfb clients Biocogent, a research and development biotechnology company that manufactures ingredients used in topical and medical skin care products. The company has recently closed a $10 million deal with …
Learn More